EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amylimycins A–C, New Bacillomycin D Analogs from Marine-Derived Bacillus amyloliquefaciens

Jaeyoun Lee iD, Seung Hyun Kim iD, Soohyun Um iD

Marine Drugs · 17.06.2026 · 24 (6) · 218

DOI: 10.3390/md24060218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 17.06.2026. Verfasst von Jaeyoun Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacillus amyloliquefaciens, Lipopeptides, Peptides, Cyclic. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marine-derived microorganisms are a rich source of structurally diverse natural products with significant pharmaceutical potential. In this study, three new cyclic lipopeptides, amylimycins A–C (1–3), were isolated from a marine-derived Bacillus amyloliquefaciens strain. The chemical structures of these compounds were elucidated through comprehensive spectroscopic analyses and chiral derivatization using 1-fluoro-2,4-dinitrophenyl-5-alanine amide (FDAA). Amylimycins A–C (1–3) were identified as bacillomycin D analogs belonging to the iturin family, characterized by a cyclic heptapeptide core linked to a β-amino fatty acid moiety. Notably, these compounds featured uncommon branched β-amino fatty acid chains with varied chain lengths, representing a distinctive structural characteristic among bacillomycin D analogs. Amylimycins A–C (1–3) showed moderate antibacterial activity against the Gram-positive bacteria Bacillus subtilis and Staphylococcus epidermidis, while displaying weak to no activity against the Gram-negative strains Escherichia coli and Pseudomonas fluorescens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacillus amyloliquefaciensLipopeptidesPeptides, CyclicAquatic OrganismsMicrobial Sensitivity TestsBacillus subtilisGram-Positive BacteriaAntimicrobial Cationic Peptides

Stichwörter der Autor:innen

Bacillus amyloliquefaciensantibacterial activitiesbacillomycin Dlipopeptides

Substanzen

Anti-Bacterial Agentsbacillomycin DLipopeptidesPeptides, CyclicAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Republic of Korea.
  • Department of Forest Products and Biotechnology, Kookmin University, Seoul 02707, Republic of Korea.

ORCID-Profile: Jaeyoun Lee, Seung Hyun Kim, Soohyun Um

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, J., Kim, S. H., & Um, S. (2026). Amylimycins A–C, New Bacillomycin D Analogs from Marine-Derived Bacillus amyloliquefaciens. Marine Drugs, 24(6), 218. https://doi.org/10.3390/md24060218

Vancouver

Lee J, Kim SH, Um S. Amylimycins A–C, New Bacillomycin D Analogs from Marine-Derived Bacillus amyloliquefaciens. Marine Drugs. 2026;24(6):218. doi:10.3390/md24060218

BibTeX
@article{Lee2026,
  author = {Lee, Jaeyoun and Kim, Seung Hyun and Um, Soohyun},
  title = {Amylimycins A–C, New Bacillomycin D Analogs from Marine-Derived Bacillus amyloliquefaciens},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {218},
  doi = {10.3390/md24060218}
}
Kostenlos starten →